However, CD137 functionality on NK cells did not lead to direct tumor killing effects; the tumor killing is performed by CD8+CD137+ T cells because the antitumor efficacy of a CD137-bispecific molecule in mouse studies was completely diminished in the absence of CD8+ T cells, while CD4+ T and NK cells were dispensable [61]. This evidence concerns the gene TNFRSF9 and neoplasm.